Overview

An Observational Study For Ambrisentan

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the programme is to collect safety data on ambrisentan when used in clinical practice
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Ambrisentan